中枢神経系（CNS）治療の世界市場（～2026年）

• 英文タイトル：Global Central Nervous System (CNS) Therapeutic Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11324
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は中枢神経系（CNS）治療のグローバル市場について調査・分析したレポートです。種類別（神経血管、外傷、メンタルヘルス、変性疾患、感染症、癌）市場規模、用途別（臨床、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別中枢神経系（CNS）治療の競争状況、市場シェア
・世界の中枢神経系（CNS）治療市場：種類別市場規模 2015年-2020年（神経血管、外傷、メンタルヘルス、変性疾患、感染症、癌）
・世界の中枢神経系（CNS）治療市場：種類別市場規模予測 2021年-2026年（神経血管、外傷、メンタルヘルス、変性疾患、感染症、癌）
・世界の中枢神経系（CNS）治療市場：用途別市場規模 2015年-2020年（臨床、その他）
・世界の中枢神経系（CNS）治療市場：用途別市場規模予測 2021年-2026年（臨床、その他）
・北米の中枢神経系（CNS）治療市場分析：米国、カナダ
・ヨーロッパの中枢神経系（CNS）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの中枢神経系（CNS）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の中枢神経系（CNS）治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの中枢神経系（CNS）治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Biogen、Johnson & Johnson、Eli Lilly、Otsuka America Pharmaceutical、Merck、Astrazeneca、Novartis、Teva Pharmaceutical Industries、Takeda
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders.
Advancements in diagnostics, therapeutics and drug discovery techniques will further trigger the growth of central nervous system therapeutic market.

Market Analysis and Insights: Global Central Nervous System (CNS) Therapeutic Market
The global Central Nervous System (CNS) Therapeutic market size is projected to reach US$ 76830 million by 2026, from US$ 74150 million in 2020, at a CAGR of 3.3%% during 2021-2026.

Global Central Nervous System (CNS) Therapeutic Scope and Market Size
Central Nervous System (CNS) Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Central Nervous System (CNS) Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Biogen
Johnson & Johnson
Eli Lilly
Otsuka America Pharmaceutical
Merck
Astrazeneca
Novartis
Teva Pharmaceutical Industries
Takeda

Market segment by Type, the product can be split into
Neurovascular
Trauma
Mental Health
Degenerative Disorder
Infections
Cancer
Market segment by Application, split into
Clinical Application
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Central Nervous System (CNS) Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Neurovascular
1.4.3 Trauma
1.4.4 Mental Health
1.4.5 Degenerative Disorder
1.4.6 Infections
1.4.7 Cancer
1.5 Market by Application
1.5.1 Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Clinical Application
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Therapeutic Market Perspective (2015-2026)
2.2 Global Central Nervous System (CNS) Therapeutic Growth Trends by Regions
2.2.1 Central Nervous System (CNS) Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Central Nervous System (CNS) Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Central Nervous System (CNS) Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Central Nervous System (CNS) Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Central Nervous System (CNS) Therapeutic Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Therapeutic Players by Market Size
3.1.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Central Nervous System (CNS) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio
3.2.1 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutic Revenue in 2019
3.3 Central Nervous System (CNS) Therapeutic Key Players Head office and Area Served
3.4 Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service
3.5 Date of Enter into Central Nervous System (CNS) Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
5.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
6.2 Central Nervous System (CNS) Therapeutic Key Players in North America (2019-2020)
6.3 North America Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
6.4 North America Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)

7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
7.2 Central Nervous System (CNS) Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
7.4 Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)

8 China
8.1 China Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
8.2 Central Nervous System (CNS) Therapeutic Key Players in China (2019-2020)
8.3 China Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
8.4 China Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)

9 Japan
9.1 Japan Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
9.2 Central Nervous System (CNS) Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
9.4 Japan Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
10.2 Central Nervous System (CNS) Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)

11 India
11.1 India Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
11.2 Central Nervous System (CNS) Therapeutic Key Players in India (2019-2020)
11.3 India Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
11.4 India Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
12.2 Central Nervous System (CNS) Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Central Nervous System (CNS) Therapeutic Introduction
13.1.4 Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Biogen
13.2.1 Biogen Company Details
13.2.2 Biogen Business Overview
13.2.3 Biogen Central Nervous System (CNS) Therapeutic Introduction
13.2.4 Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.2.5 Biogen Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Introduction
13.3.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Introduction
13.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 Otsuka America Pharmaceutical
13.5.1 Otsuka America Pharmaceutical Company Details
13.5.2 Otsuka America Pharmaceutical Business Overview
13.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Introduction
13.5.4 Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.5.5 Otsuka America Pharmaceutical Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Central Nervous System (CNS) Therapeutic Introduction
13.6.4 Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Astrazeneca
13.7.1 Astrazeneca Company Details
13.7.2 Astrazeneca Business Overview
13.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Introduction
13.7.4 Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.7.5 Astrazeneca Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Central Nervous System (CNS) Therapeutic Introduction
13.8.4 Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Teva Pharmaceutical Industries
13.9.1 Teva Pharmaceutical Industries Company Details
13.9.2 Teva Pharmaceutical Industries Business Overview
13.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Introduction
13.9.4 Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.9.5 Teva Pharmaceutical Industries Recent Development
13.10 Takeda
13.10.1 Takeda Company Details
13.10.2 Takeda Business Overview
13.10.3 Takeda Central Nervous System (CNS) Therapeutic Introduction
13.10.4 Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.10.5 Takeda Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Central Nervous System (CNS) Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Central Nervous System (CNS) Therapeutic Revenue
Table 3. Ranking of Global Top Central Nervous System (CNS) Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Neurovascular
Table 6. Key Players of Trauma
Table 7. Key Players of Mental Health
Table 8. Key Players of Degenerative Disorder
Table 9. Key Players of Infections
Table 10. Key Players of Cancer
Table 11. Global Central Nervous System (CNS) Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Central Nervous System (CNS) Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Central Nervous System (CNS) Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Central Nervous System (CNS) Therapeutic Market Share by Regions (2015-2020)
Table 15. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Central Nervous System (CNS) Therapeutic Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Central Nervous System (CNS) Therapeutic Market Growth Strategy
Table 21. Main Points Interviewed from Key Central Nervous System (CNS) Therapeutic Players
Table 22. Global Central Nervous System (CNS) Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 23. Global Central Nervous System (CNS) Therapeutic Market Share by Players (2015-2020)
Table 24. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2019)
Table 25. Global Central Nervous System (CNS) Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service
Table 28. Date of Enter into Central Nervous System (CNS) Therapeutic Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 31. Global Central Nervous System (CNS) Therapeutic Market Size Share by Type (2015-2020)
Table 32. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2021-2026)
Table 33. Global Central Nervous System (CNS) Therapeutic Market Size Share by Application (2015-2020)
Table 34. Global Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 35. Global Central Nervous System (CNS) Therapeutic Market Size Share by Application (2021-2026)
Table 36. North America Key Players Central Nervous System (CNS) Therapeutic Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Central Nervous System (CNS) Therapeutic Market Share (2019-2020)
Table 38. North America Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 39. North America Central Nervous System (CNS) Therapeutic Market Share by Type (2015-2020)
Table 40. North America Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 41. North America Central Nervous System (CNS) Therapeutic Market Share by Application (2015-2020)
Table 42. Europe Key Players Central Nervous System (CNS) Therapeutic Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Central Nervous System (CNS) Therapeutic Market Share (2019-2020)
Table 44. Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Central Nervous System (CNS) Therapeutic Market Share by Type (2015-2020)
Table 46. Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Central Nervous System (CNS) Therapeutic Market Share by Application (2015-2020)
Table 48. China Key Players Central Nervous System (CNS) Therapeutic Revenue (2019-2020) (Million US$)
Table 49. China Key Players Central Nervous System (CNS) Therapeutic Market Share (2019-2020)
Table 50. China Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 51. China Central Nervous System (CNS) Therapeutic Market Share by Type (2015-2020)
Table 52. China Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 53. China Central Nervous System (CNS) Therapeutic Market Share by Application (2015-2020)
Table 54. Japan Key Players Central Nervous System (CNS) Therapeutic Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Central Nervous System (CNS) Therapeutic Market Share (2019-2020)
Table 56. Japan Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Central Nervous System (CNS) Therapeutic Market Share by Type (2015-2020)
Table 58. Japan Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Central Nervous System (CNS) Therapeutic Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Central Nervous System (CNS) Therapeutic Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Central Nervous System (CNS) Therapeutic Market Share (2019-2020)
Table 62. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Central Nervous System (CNS) Therapeutic Market Share by Type (2015-2020)
Table 64. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Central Nervous System (CNS) Therapeutic Market Share by Application (2015-2020)
Table 66. India Key Players Central Nervous System (CNS) Therapeutic Revenue (2019-2020) (Million US$)
Table 67. India Key Players Central Nervous System (CNS) Therapeutic Market Share (2019-2020)
Table 68. India Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 69. India Central Nervous System (CNS) Therapeutic Market Share by Type (2015-2020)
Table 70. India Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 71. India Central Nervous System (CNS) Therapeutic Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Central Nervous System (CNS) Therapeutic Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Central Nervous System (CNS) Therapeutic Market Share (2019-2020)
Table 74. Central & South America Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Central Nervous System (CNS) Therapeutic Market Share by Type (2015-2020)
Table 76. Central & South America Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Central Nervous System (CNS) Therapeutic Market Share by Application (2015-2020)
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Product
Table 81. Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020) (Million US$)
Table 82. Pfizer Recent Development
Table 83. Biogen Company Details
Table 84. Biogen Business Overview
Table 85. Biogen Product
Table 86. Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020) (Million US$)
Table 87. Biogen Recent Development
Table 88. Johnson & Johnson Company Details
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Product
Table 91. Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020) (Million US$)
Table 92. Johnson & Johnson Recent Development
Table 93. Eli Lilly Company Details
Table 94. Eli Lilly Business Overview
Table 95. Eli Lilly Product
Table 96. Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020) (Million US$)
Table 97. Eli Lilly Recent Development
Table 98. Otsuka America Pharmaceutical Company Details
Table 99. Otsuka America Pharmaceutical Business Overview
Table 100. Otsuka America Pharmaceutical Product
Table 101. Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020) (Million US$)
Table 102. Otsuka America Pharmaceutical Recent Development
Table 103. Merck Company Details
Table 104. Merck Business Overview
Table 105. Merck Product
Table 106. Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020) (Million US$)
Table 107. Merck Recent Development
Table 108. Astrazeneca Company Details
Table 109. Astrazeneca Business Overview
Table 110. Astrazeneca Product
Table 111. Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020) (Million US$)
Table 112. Astrazeneca Recent Development
Table 113. Novartis Business Overview
Table 114. Novartis Product
Table 115. Novartis Company Details
Table 116. Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020) (Million US$)
Table 117. Novartis Recent Development
Table 118. Teva Pharmaceutical Industries Company Details
Table 119. Teva Pharmaceutical Industries Business Overview
Table 120. Teva Pharmaceutical Industries Product
Table 121. Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020) (Million US$)
Table 122. Teva Pharmaceutical Industries Recent Development
Table 123. Takeda Company Details
Table 124. Takeda Business Overview
Table 125. Takeda Product
Table 126. Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020) (Million US$)
Table 127. Takeda Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Central Nervous System (CNS) Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Neurovascular Features
Figure 3. Trauma Features
Figure 4. Mental Health Features
Figure 5. Degenerative Disorder Features
Figure 6. Infections Features
Figure 7. Cancer Features
Figure 8. Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2020 VS 2026
Figure 9. Clinical Application Case Studies
Figure 10. Others Case Studies
Figure 11. Central Nervous System (CNS) Therapeutic Report Years Considered
Figure 12. Global Central Nervous System (CNS) Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Central Nervous System (CNS) Therapeutic Market Share by Regions: 2020 VS 2026
Figure 14. Global Central Nervous System (CNS) Therapeutic Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Central Nervous System (CNS) Therapeutic Market Share by Players in 2019
Figure 17. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Therapeutic Revenue in 2019
Figure 19. North America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介

クローン病診断・治療の世界市場（～2026年）

Global Crohn's Disease Diagnostic and Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY11531 2020年11月25日 96Pages
当調査資料はクローン病診断・治療のグローバル市場について調査・分析したレポートです。種類別（血液検査、糞便検査、結腸内視鏡検査、軟式S状結腸鏡検査、コンピューター断層撮影、磁気共鳴画像法、カプセル内視鏡検査）市場規模、用途別（クリニック、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...

中枢神経系疾患治療薬の世界市場（～2026年）

Global Drugs for Central Nervous System Diseases Market Size, Status and Forecast 2020-2026
MRC2-11QY11723 2020年11月25日 95Pages
当調査資料は中枢神経系疾患治療薬のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、抗不安薬、抗躁病、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

血液疾患診断・治療の世界市場（～2026年）

Global Hematological Disorders Diagnostic and Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY12149 2020年11月25日 96Pages
当調査資料は血液疾患診断・治療のグローバル市場について調査・分析したレポートです。種類別（薬剤、物質）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メ...

軽度認知障害（MCI）治療の世界市場（～2026年）

Global Mild Cognitive Impairment Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY12693 2020年11月25日 126Pages
当調査資料は軽度認知障害（MCI）治療のグローバル市場について調査・分析したレポートです。種類別（BAN-2401、ボスチニブ、ブレキサノロン、CSP-1103、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

リンパ芽球性リンパ腫治療薬の世界市場（～2026年）

Global Lymphoblastic Lymphoma Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY12558 2020年11月25日 97Pages
当調査資料はリンパ芽球性リンパ腫治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法、幹細胞移植、標的療法、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

濾胞性リンパ腫治療の世界市場（～2026年）

Global Follicular Lymphoma Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY11978 2020年11月25日 99Pages
当調査資料は濾胞性リンパ腫治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、モノクローナル抗体、幹細胞移植）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

色素沈着障害治療の世界市場（～2026年）

Global Pigmentation Disorder Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY04274 2020年11月20日 91Pages
当調査資料は色素沈着障害治療のグローバル市場について調査・分析したレポートです。種類別（薬物療法（外用薬、ハイドロキノン、L-アスコルビン酸、その他）、美容治療（ケミカルピーリング、レーザー治療、植皮、その他））市場規模、用途別（皮膚科クリニック、ドラッグストア・化粧品店、エステティッククリニック、...

白血病治療の世界市場（～2026年）

Global Leukemia Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY12503 2020年11月25日 96Pages
当調査資料は白血病治療のグローバル市場について調査・分析したレポートです。種類別（誘導療法、強化療法、維持療法）市場規模、用途別（がん研究センター、診断研究所、クリニック、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...

ループス治療の世界市場（～2026年）

Global Lupus Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY12555 2020年11月25日 96Pages
当調査資料はループス治療のグローバル市場について調査・分析したレポートです。種類別（B細胞モジュレーター、T細胞モジュレーター、免疫抑制剤・細胞毒性薬、炎症誘発性・サイトカイン阻害剤、その他）市場規模、用途別（クリニック、病院、診療所研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...

副鼻腔治療薬の世界市場（～2026年）

Global Sinus Therapeutic Drug Market Size, Status and Forecast 2020-2026
MRC2-11QY04622 2020年11月20日 94Pages
当調査資料は副鼻腔治療薬のグローバル市場について調査・分析したレポートです。種類別（経口、局所、注射可能）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

中枢神経系疾患治療薬の世界市場（～2026年） A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous system Market Analysis and Insights: Global Drugs for Central Nervous System Diseases Market The global Drugs for Central Nervous System Diseases market size is projected to reac…
色素沈着障害治療の世界市場（～2026年） Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color. Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are availabl…
糖尿病性神経障害治療薬の世界市場（～2026年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CA…
乳癌治療の世界市場（～2026年） Market Analysis and Insights: Global Breast Cancer Therapeutic Market The global Breast Cancer Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Breast Cancer Therapeutic Scope and Market Size Breast Cancer T…
双極性障害治療の世界市場（～2026年） Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. Accord…